Cargando…
Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study
PURPOSE: Although there have been reported cases of drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome caused by antituberculosis drugs, there has been no research to examine its prevalence. This study assessed the prevalence and clinical characteristics of DRESS syndrome caused...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267186/ https://www.ncbi.nlm.nih.gov/pubmed/30479080 http://dx.doi.org/10.4168/aair.2019.11.1.90 |
_version_ | 1783376009539616768 |
---|---|
author | Jung, Ho Yeon Park, Sunmin Shin, Beomsu Lee, Ji-Ho Lee, Seok Jeong Lee, Myoung Kyu Lee, Won-Yeon Yong, Suk Joong Kim, Sang-Ha |
author_facet | Jung, Ho Yeon Park, Sunmin Shin, Beomsu Lee, Ji-Ho Lee, Seok Jeong Lee, Myoung Kyu Lee, Won-Yeon Yong, Suk Joong Kim, Sang-Ha |
author_sort | Jung, Ho Yeon |
collection | PubMed |
description | PURPOSE: Although there have been reported cases of drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome caused by antituberculosis drugs, there has been no research to examine its prevalence. This study assessed the prevalence and clinical characteristics of DRESS syndrome caused by antituberculosis drugs. METHODS: The electronic medical records of a cohort consisting of adult patients diagnosed with tuberculosis between July 2006 and June 2010 were reviewed and retrospectively inspected. We searched the surveillance system for adverse drug reactions and the electronic medical records to identify patients who reported severe cutaneous adverse reactions to antituberculosis drugs. These patients were then re-assessed using a European Registry of Severe Cutaneous Adverse Reactions to Drugs and Collection of Biological Samples (RegiSCAR) scoring system. Clinical characteristics, including the symptoms and latency of DRESS syndrome, the therapeutic dosage and period of steroids, and the final duration of tuberculosis therapy, were examined. RESULTS: Of the 1,253 adult patients with tuberculosis receiving antituberculosis drugs, 15 were identified as potential cases of DRESS syndrome (prevalence of 1.2%). Ethambutol was the most frequently used drug (53.5%), followed by rifampicin (26.7%), pyrazinamide (20.0%), streptomycin (13.3%), and isoniazid (6.7%). The median latency after day 1 of antituberculosis medication was 42 days. The median daily dose of steroids, expressed in prednisone-equivalent units, was 33-mg/day, and the median dosing period was 14 days. The duration of tuberculosis treatment was 76 days longer than the standard treatment period of 180 days. There was a significant difference in the peak eosinophil counts of DRESS syndrome patients according to RegiSCAR scores. Moreover, there was a significant quantitative correlation between the RegiSCAR score and peak eosinophil count. A negative correlation was also found between the RegiSCAR score and latency. CONCLUSIONS: This study confirmed the prevalence of DRESS syndrome in a cohort of adult patients with tuberculosis. |
format | Online Article Text |
id | pubmed-6267186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease |
record_format | MEDLINE/PubMed |
spelling | pubmed-62671862019-01-01 Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study Jung, Ho Yeon Park, Sunmin Shin, Beomsu Lee, Ji-Ho Lee, Seok Jeong Lee, Myoung Kyu Lee, Won-Yeon Yong, Suk Joong Kim, Sang-Ha Allergy Asthma Immunol Res Original Article PURPOSE: Although there have been reported cases of drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome caused by antituberculosis drugs, there has been no research to examine its prevalence. This study assessed the prevalence and clinical characteristics of DRESS syndrome caused by antituberculosis drugs. METHODS: The electronic medical records of a cohort consisting of adult patients diagnosed with tuberculosis between July 2006 and June 2010 were reviewed and retrospectively inspected. We searched the surveillance system for adverse drug reactions and the electronic medical records to identify patients who reported severe cutaneous adverse reactions to antituberculosis drugs. These patients were then re-assessed using a European Registry of Severe Cutaneous Adverse Reactions to Drugs and Collection of Biological Samples (RegiSCAR) scoring system. Clinical characteristics, including the symptoms and latency of DRESS syndrome, the therapeutic dosage and period of steroids, and the final duration of tuberculosis therapy, were examined. RESULTS: Of the 1,253 adult patients with tuberculosis receiving antituberculosis drugs, 15 were identified as potential cases of DRESS syndrome (prevalence of 1.2%). Ethambutol was the most frequently used drug (53.5%), followed by rifampicin (26.7%), pyrazinamide (20.0%), streptomycin (13.3%), and isoniazid (6.7%). The median latency after day 1 of antituberculosis medication was 42 days. The median daily dose of steroids, expressed in prednisone-equivalent units, was 33-mg/day, and the median dosing period was 14 days. The duration of tuberculosis treatment was 76 days longer than the standard treatment period of 180 days. There was a significant difference in the peak eosinophil counts of DRESS syndrome patients according to RegiSCAR scores. Moreover, there was a significant quantitative correlation between the RegiSCAR score and peak eosinophil count. A negative correlation was also found between the RegiSCAR score and latency. CONCLUSIONS: This study confirmed the prevalence of DRESS syndrome in a cohort of adult patients with tuberculosis. The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2018-10-10 /pmc/articles/PMC6267186/ /pubmed/30479080 http://dx.doi.org/10.4168/aair.2019.11.1.90 Text en Copyright © 2019 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Jung, Ho Yeon Park, Sunmin Shin, Beomsu Lee, Ji-Ho Lee, Seok Jeong Lee, Myoung Kyu Lee, Won-Yeon Yong, Suk Joong Kim, Sang-Ha Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study |
title | Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study |
title_full | Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study |
title_fullStr | Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study |
title_full_unstemmed | Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study |
title_short | Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study |
title_sort | prevalence and clinical features of drug reactions with eosinophilia and systemic symptoms syndrome caused by antituberculosis drugs: a retrospective cohort study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267186/ https://www.ncbi.nlm.nih.gov/pubmed/30479080 http://dx.doi.org/10.4168/aair.2019.11.1.90 |
work_keys_str_mv | AT junghoyeon prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy AT parksunmin prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy AT shinbeomsu prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy AT leejiho prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy AT leeseokjeong prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy AT leemyoungkyu prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy AT leewonyeon prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy AT yongsukjoong prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy AT kimsangha prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy |